Showing results (21-30 of 796) with videos related to
Sort By:
Pageof 80
Diabetes, Obesity & Metabolism|October 18, 2007
Pharmacological intervention in prediabetes: considering the risks and benefitsS Del Prato, C Bianchi, R Miccoli, et al.Diabetes, Obesity & Metabolism|September 30, 2011
The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemiaR A DeFronzo, J A Davidson, S Del PratoActa Diabetologica|January 6, 2004
Hyperglycaemia and cardiovascular riskF Palumbo, C Bianchi, R Miccoli, et al.Acta Diabetologica Latina|January 1, 1989
'Do-it-yourself' insulin pump. Case reportD Bruttomesso, G Lisato, S Del Prato, et al.Diabetes, Obesity & Metabolism|August 19, 2014
Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year studyS Del Prato, R Camisasca, C Wilson, et al.Diabetes, Obesity & Metabolism|February 12, 2016
Comparison of alogliptin and glipizide for composite endpoint of glycated haemoglobin reduction, no hypoglycaemia and no weight gain in type 2 diabetes mellitusS Del Prato, P Fleck, C Wilson, et al.International Journal of Clinical Practice|May 12, 2010
Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes ManagementS Del Prato, J LaSalle, S Matthaei, et al.International Journal of Clinical Practice|October 21, 2005
Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic controlC J Bailey, S Del Prato, D Eddy, et al.The American Journal of Physiology|January 1, 1990
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolismP Castellino, L Luzi, S Del Prato, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 4, 2016
Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trialsS Del Prato, S Patel, S Crowe, et al.Pageof 80